Elastomeric Infusion Pumps Market Report 2024

This Elastomeric Infusion Pumps industry report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The elastomeric infusion pumps market size has grown strongly in recent years. It will grow from $0.98 billion in 2023 to $1.07 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth during the historic period can be attributed to the high incidence of chronic conditions, an increase in surgical procedures, a growing aging population, enhanced awareness and education, and increased government programs and funding.

The elastomeric infusion pumps market size is expected to see strong growth in the next few years. It will grow to $1.53 billion in 2028 at a compound annual growth rate (CAGR) of 9.5%. The anticipated growth during the forecast period can be attributed to the increasing prevalence of chronic diseases, a rising elderly population, a growing number of surgical interventions, and higher healthcare expenditure. Key trends expected to drive this growth include the development of smart infusion pumps with IoT integration, advanced anti-free-flow mechanisms, ergonomic and user-friendly designs, longer battery life, eco-friendly materials, and advancements in microengineering and materials science.

The rising number of hospitalized patients is anticipated to boost the growth of the elastomeric infusion pump market. Hospitalized patients require medical treatment and care, which often involves ongoing monitoring and specific interventions. With advances in medical technology enabling more complex and effective treatments, there has been an increase in hospital admissions for surgeries and procedures. Elastomeric infusion pumps are designed to allow patients to receive necessary medications, such as antibiotics, pain management, or chemotherapy, at home rather than in the hospital. This capability supports early discharge, helping to free up hospital beds and reduce hospital occupancy rates. For example, a report by the National Health Service (NHS) in December 2023 noted that there were 408,700 hospital admissions in England during 2022-2023, representing a 5% increase from 389,800 admissions in 2021-2022. This growing number of hospitalizations is expected to drive the elastomeric infusion pump market.

Companies in the elastomeric infusion pump market are developing portable chemotherapy infusion pumps to offer more reliable and user-friendly systems for precise drug delivery. These portable pumps allow patients to receive chemotherapy drugs either continuously or intermittently outside a hospital setting. For instance, in March 2022, Shanghai MicroPort Lifesciences Co. Ltd., a China-based medical device company, introduced the AutoEx. This device is designed for the controlled infusion of chemotherapy drugs, featuring a dual CPU control system and a disposable pump infusion unit with two fluid reservoir bags. The AutoEx allows for automatic switching between the reservoirs to ensure uninterrupted medication delivery, enhancing patient comfort and reducing manual intervention by healthcare professionals. Although the AutoEx operates within the same therapeutic space as traditional elastomeric infusion pumps, it brings additional innovations to the field.

In June 2022, Delta Med GmbH, an Italy-based provider of vascular access devices, entered into a partnership with Adria Med. This collaboration aims to strengthen Delta Med’s capabilities in the infusion medical device sector, resulting in a more comprehensive product portfolio and improved service delivery across Italy and Europe. Both companies plan to leverage their combined expertise and resources to drive growth while maintaining high standards for their products and services. Adria Med, an Italy-based manufacturer of elastomeric infusion pumps, will contribute to this expanded collaboration.

Major companies operating in the elastomeric infusion pumps market are Baxter International Inc., Medline Industries, B. Braun Melsungen AG, Nipro Corporation, Avanos Medical Inc., Vygon SAS, pfm medical gmbh, Integrated Medical Systems Inc., Preferred Medical, Leventon S.A.U, Tuoren Medical, Eitan Medical, PROMECON GmbH, Epic Medical, Promecon Medical, Ace Medical Devices, Gamastech, Adria Med, Heka Healthcare, Beijing KellyMed Co. Ltd.

North America was the largest region in the elastomeric infusion pump market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the elastomeric infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the elastomeric infusion pumps market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Elastomeric infusion pumps are medical devices designed for the controlled delivery of medications or fluids over a specified duration. They are appreciated for their simplicity, portability, and user-friendliness, making them valuable in both hospital and home care environments. These pumps facilitate treatment outside clinical settings, offering patients greater mobility and flexibility during infusion therapy.

The primary types of elastomeric infusion pumps are continuous-rate and variable-rate pumps. Variable-rate pumps allow healthcare providers to adjust the infusion rates by altering the pressure within the elastomeric balloon or using different flow restrictors, ensuring treatment is customized to meet individual patient needs. These pumps are utilized in various treatments, including pain management, antibiotics or antivirals, chemotherapy, and more, and are employed across different settings such as hospitals, ambulatory surgical centers, home care environments, and clinics.

The elastomeric infusion pump market research report is one of a series of new reports that provides elastomeric infusion pump market statistics, including elastomeric infusion pump industry global market size, regional shares, competitors with an elastomeric infusion pump market share, detailed elastomeric infusion pump market segments, market trends, and opportunities, and any further data you may need to thrive in the elastomeric infusion pump industry. This elastomeric infusion pump market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The elastomeric infusion pumps market consists of sales of tubing sets, medication reservoirs, filters, needles and catheters, connectors, and adaptors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.